FDA’s Revised Draft For Compounding Pharmacies Opens Door To Compounding For Office Use

FDA’s revised draft guidance on GMPs for outsourcing pharmacy compounding operations responds to calls to allow the compounding of small quantities of drugs presumably for office use. The IACP applauds the move.